130 related articles for article (PubMed ID: 11769096)
1. [Microbiological research for the Hungarian pharmaceutical industry].
Ambrus G
Acta Pharm Hung; 2001; 71(1):44-56. PubMed ID: 11769096
[TBL] [Abstract][Full Text] [Related]
2. [History and major achievements of the Institute for Drug Research].
Simay A
Acta Pharm Hung; 2001; 71(1):7-12. PubMed ID: 11769099
[TBL] [Abstract][Full Text] [Related]
3. Microbiological research for the Hungarian pharmaceutical industry.
Ambrus G
Pharmazie; 2001 Oct; 56 Suppl 1():S34-41. PubMed ID: 11686089
[TBL] [Abstract][Full Text] [Related]
4. Antibacterial research and development in the 21(st) Century--an industry perspective of the challenges.
Thomson CJ; Power E; Ruebsamen-Waigmann H; Labischinski H
Curr Opin Microbiol; 2004 Oct; 7(5):445-50. PubMed ID: 15451498
[TBL] [Abstract][Full Text] [Related]
5. The historical delivery of antibiotics from microbial natural products--can history repeat?
Peláez F
Biochem Pharmacol; 2006 Mar; 71(7):981-90. PubMed ID: 16290171
[TBL] [Abstract][Full Text] [Related]
6. Natural products--the future scaffolds for novel antibiotics?
Butler MS; Buss AD
Biochem Pharmacol; 2006 Mar; 71(7):919-29. PubMed ID: 16289393
[TBL] [Abstract][Full Text] [Related]
7. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
8. The future of natural products as a source of new antibiotics.
Luzhetskyy A; Pelzer S; Bechthold A
Curr Opin Investig Drugs; 2007 Aug; 8(8):608-13. PubMed ID: 17668363
[TBL] [Abstract][Full Text] [Related]
9. Antibiotics: where did we go wrong?
Overbye KM; Barrett JF
Drug Discov Today; 2005 Jan; 10(1):45-52. PubMed ID: 15676298
[TBL] [Abstract][Full Text] [Related]
10. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
11. The role of natural product chemistry in drug discovery.
Butler MS
J Nat Prod; 2004 Dec; 67(12):2141-53. PubMed ID: 15620274
[TBL] [Abstract][Full Text] [Related]
12. [Transformation of steroids by actinobacteria: a review].
Donova MV
Prikl Biokhim Mikrobiol; 2007; 43(1):5-18. PubMed ID: 17345852
[TBL] [Abstract][Full Text] [Related]
13. The value of natural products to future pharmaceutical discovery.
Baker DD; Chu M; Oza U; Rajgarhia V
Nat Prod Rep; 2007 Dec; 24(6):1225-44. PubMed ID: 18033577
[TBL] [Abstract][Full Text] [Related]
14. [Tuberculosis and its control--lessons from the past and future prospect].
Shimao T
Kekkaku; 2005 Jun; 80(6):481-9. PubMed ID: 16130906
[TBL] [Abstract][Full Text] [Related]
15. Glycodiversification for the optimization of the kanamycin class aminoglycosides.
Wang J; Li J; Chen HN; Chang H; Tanifum CT; Liu HH; Czyryca PG; Chang CW
J Med Chem; 2005 Oct; 48(20):6271-85. PubMed ID: 16190754
[TBL] [Abstract][Full Text] [Related]
16. Upflow anaerobic sludge blanket reactor--a review.
Bal AS; Dhagat NN
Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
[TBL] [Abstract][Full Text] [Related]
17. Trends in antimicrobial drug development: implications for the future.
Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
[TBL] [Abstract][Full Text] [Related]
18. Exploiting current understanding of antibiotic action for discovery of new drugs.
Chopra I; Hesse L; O'Neill AJ
J Appl Microbiol; 2002; 92 Suppl():4S-15S. PubMed ID: 12000608
[TBL] [Abstract][Full Text] [Related]
19. [Contraceptive development--the view from the U.S.A. in the mid 80s].
Potts M; Siemens A; Burton N
Contracept Fertil Sex (Paris); 1986 Mar; 14(3):247-51. PubMed ID: 12268061
[TBL] [Abstract][Full Text] [Related]
20. Potential and capabilities of hydroxynitrile lyases as biocatalysts in the chemical industry.
Purkarthofer T; Skranc W; Schuster C; Griengl H
Appl Microbiol Biotechnol; 2007 Aug; 76(2):309-20. PubMed ID: 17607575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
